← board
TCRG
distress 6/10 · elevated risk$0.00-85%today-100% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
0%
Price & events
-99.4% over 6M
CatalystRating changeDilutionFinancingdashed = today
-85.0%
1D
-99.4%
1W
-99.4%
1M
-66.9%
3M
-99.4%
6M
-98.3%
1Y
—
2Y
—
5Y
-98.5%
All
Overview
- Market Cap
- $272.07K
- Volume
- 350
- 52 Week Range
- $0.00 – $2.30
- Total Shares
- 60.46M
- Float Shares
- 18.46M
- % Held by Insiders
- 68.15%
- % Held by Institutions
- 0.00%
- RVOL
- 0.05x
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 60,459,890 · 0 offerings/1y · 0 PIPEs
- 2025-03-28EFFECTshelf_effective
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.